Dr. Dharma Choudhary is a distinguished clinician in Hematology & Marrow Transplant with over 20 years of experience. Renowned for his patient-centric approach, Dr. Choudhary has performed over 1800 stem cell transplants, including more than 1300 independently on both pediatric and adult patients with hematological disorders. He has established major Blood and Marrow Transplant programs in Delhi and Mumbai and specializes in transplants for hemoglobinopathies (like Thalassemia Major & Sickle Cell Disease), bone marrow failure syndromes (such as Aplastic Anemia and Fanconi Anemia), haploidentical transplants, and graft-versus-host disease. Dr. Choudhary completed his post-graduation in Internal Medicine and DM in Clinical Hematology from AIIMS, New Delhi, and a fellowship through the Leukemia/BMT Program of British Columbia, Canada. A life member of the Indian Society of Hematology & Transfusion Medicine (ISHTM), he has authored over 60 publications and is an esteemed teacher and researcher globally.

Dr. Dharma Choudhary: Expertise and Experience
  • Experience: Over 20 years in Hematology & Marrow Transplant.
  • Procedures: Accomplished more than 1800 stem cell transplants, including over 1300 independently.
  • Specialization: Transplants for Hemoglobinopathies (Thalassemia Major & Sickle Cell Disease), Bone Marrow Failure Syndromes (Aplastic Anemia, Fanconi Anemia), Haploidentical Transplants, Graft versus Host Disease.

Notable Achievements

  • Program Development: Established major Blood and Marrow Transplant programs in Delhi and Mumbai.
  • Transplants: Successfully conducted over 1000 Allogenic and 300 Autologous Stem Cell Transplants.
  • Teaching and Research: Authored 60+ publications, presented globally at ASBMT, APBMT, EBMT, and ISBMT.

Memberships and Awards

  • Memberships: Indian Society of Hematology & Transfusion Medicine (ISHTM), Medical Council of India, Delhi Medical Council, Rajasthan Medical Council.
  • Global Presence: Presented research in 20+ countries, including the USA, Canada, China, and UAE.